Back to Search
Start Over
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer.
- Source :
- Clinical Lung Cancer; May2021, Vol. 22 Issue 3, pe379-e389, 11p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15257304
- Volume :
- 22
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Lung Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 150825988
- Full Text :
- https://doi.org/10.1016/j.cllc.2020.05.028